Detalhe da pesquisa
1.
Ovarian cancer mutational processes drive site-specific immune evasion.
Nature
; 612(7941): 778-786, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517593
2.
A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers.
Cancer
; 130(10): 1733-1746, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38422006
3.
Pathogenic germline variants in patients with endometrial cancer of diverse ancestry.
Cancer
; 130(4): 576-587, 2024 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37886874
4.
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.
Gynecol Oncol
; 180: 35-43, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041901
5.
Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake.
Gynecol Oncol
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493020
6.
Moving into the modern era of molecular classification for endometrial cancer.
J Surg Oncol
; 129(1): 120-125, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100711
7.
Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer.
Int J Gynecol Cancer
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782452
8.
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
Int J Gynecol Cancer
; 34(5): 697-704, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38508587
9.
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series.
Int J Gynecol Cancer
; 34(4): 594-601, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38296517
10.
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management.
Gynecol Oncol
; 170: 93-101, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36669327
11.
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecol Oncol
; 176: 69-75, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37454565
12.
Germline drivers of gynecologic carcinosarcomas.
Gynecol Oncol
; 174: 34-41, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37149903
13.
Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer.
Int J Gynecol Cancer
; 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38088180
14.
Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants.
Cancer
; 128(21): 3870-3879, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041233
15.
Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome.
Genet Med
; 24(6): 1187-1195, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35346574
16.
Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis.
Gynecol Oncol
; 166(3): 425-431, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803835
17.
Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines.
Int J Gynecol Cancer
; 32(1): 79-88, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903560
18.
Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series.
Int J Gynecol Cancer
; 32(8): 1017-1024, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545291
19.
The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer?
J Natl Compr Canc Netw
; 19(7): 871-878, 2021 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34340209
20.
Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study.
Int J Gynecol Cancer
; 30(12): 1915-1921, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106271